Abstract
Introduction: Most unicompartmental knee replacements (UKRs) employ cement for fixation of the prosthetic components to the bone. The information in the literature about the relative merits of cemented and cementless UKR is contradictory, with some favouring cementless fixation while others favouring cemented fixation. There is concern about the radiolucency which frequently develops around the tibial component with cemented fixations. The exact cause of the occurrence of radiolucency is unknown but according to some, it may suggest suboptimal fixation.
Method: Following ethical approval, 62 patients with medial OA were randomised to receive either cemented (n=31) or cementless components (n=31). All patients underwent identical surgical procedure with either a cemented or cementless Oxford UKR. Patients were assessed clinically and radiologically. The x-rays were taken with an image intensifier (I.I.). The position of the I.I. was adjusted until it was perfectly aligned with the tibial bone-implant interface thereby allowing accurate assessment of presence and extent of the radiolucency.
Results: The patients in the two groups were well matched. There was no significant difference in the clinical scores between the two groups. The mean OKS for the cemented group was 40 (± 8.3) and 42 (± 4.6) for cementless group. Narrow radiolucent lines were seen at the bone-implant interfaces of 75% of the cemented tibial components; partial in 43% and complete in 32%. In the cementless implants, partial radiolucencies were seen in 7% and complete radiolucencies in none. The differences are statistically highly significant (p< 0.0001) and imply satisfactory bone ingrowth into the cementless implants.
Conclusions: The method of fixation influences the incidence of radiolucency. With identical designs, no patient with cementless components developed any complete radiolucency. The observation raises the question as to whether cementless rather than cemented components should be routinely used for UKR.
Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Email: office@efort.org